A carregar...
Equity in HTA: what doesn’t get measured, gets marginalised
When making recommendations about the public funding of new health technologies, policy makers typically pay close attention to quantitative evidence about the comparative effectiveness, cost effectiveness and budget impact of those technologies – what we might call “efficiency” criteria. Less atten...
Na minha lista:
| Publicado no: | Isr J Health Policy Res |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5502411/ https://ncbi.nlm.nih.gov/pubmed/28694961 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13584-017-0162-3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|